Jun 1 2023 |
SCCS Updates Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation |
Bergeson & Campbell, P.C. |
Jun 1 2023 |
Unpacking Averages: Understanding the Potential for Bias in a Sepsis Prediction Algorithm, a Case Study |
Epstein Becker & Green, P.C. |
Jun 1 2023 |
CMS Proposing Major Changes to Medicaid Drug Rebate Program |
Blank Rome LLP |
Jun 1 2023 |
EPA Issues Final Rule to Accelerate Use of Plant-Incorporated Biotechnologies |
Bergeson & Campbell, P.C. |
Jun 1 2023 |
Marketing Implications of California’s Proposition 12 |
Keller and Heckman LLP |
Jun 1 2023 |
Minnesota PFAS Ban the Broadest in the Nation |
CMBG3 Law |
Jun 1 2023 |
BETO Announces Novel State-of-the-Art Workflow Technology to Accelerate Biomanufacturing Research |
Bergeson & Campbell, P.C. |
Jun 1 2023 |
ANSES Calls for the EC to Adopt a “More Protective” Definition of Nanomaterials |
Bergeson & Campbell, P.C. |
Jun 1 2023 |
Minnesota Worker Safety Legislation for Meatpacking and Warehouse Industries Signed Into Law |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Jun 1 2023 |
This Week in 340B: May 23 – 30, 202 |
McDermott Will & Schulte LLP |
May 31 2023 |
AAFCO Comments on the Pet Food Institute’s Proposed New Federalized Regulatory System for Pet Food |
Keller and Heckman LLP |
May 31 2023 |
South Korea Looks to Tighten Biometrics Laws Amid Generative AI |
Squire Patton Boggs (US) LLP |
May 31 2023 |
Majority of States Have Legalized Marijuana, but OSHA’s Post-Incident Drug-Testing Guidance Hasn’t Changed |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
May 30 2023 |
FDA Studies Foreshadow Potential Changes to Direct-to-Consumer Prescription Drug Advertising |
Nelson Mullins |
May 30 2023 |
EPA Proposes Updates to TSCA New Chemicals Regulations; Comments Due July 25, 2023 |
Bergeson & Campbell, P.C. |
May 30 2023 |
Trending in Telehealth: May 16 – 22, 2023 |
McDermott Will & Schulte LLP |
May 29 2023 |
New Washington State Law Will Protect Job Applicants From Discrimination Based on Off-Duty Marijuana Use |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
May 28 2023 |
New Consumer Product Safety Regulations In The EU |
Barnes & Thornburg LLP |
May 26 2023 |
ECHA Publishes Annual Report on Helpdesk Activities |
Bergeson & Campbell, P.C. |
May 26 2023 |
China Proposes to Amend GB 4806.1 General Safety Standard for Food-Contact Materials |
Keller and Heckman LLP |
May 26 2023 |
Analogous Art Must Be Compared to Challenged Patent |
McDermott Will & Schulte LLP |
May 26 2023 |
Mcdermottplus Check-Up: May 26, 2023 |
McDermott Will & Schulte LLP |
May 25 2023 |
Florida Bans Offshoring of Certain Patient Information |
Sheppard, Mullin, Richter & Hampton LLP |
May 25 2023 |
Supreme Court Unanimously Affirms Amgen Repatha® Antibody Patents Invalid for Lack of Enablement |
Mintz |
May 25 2023 |
Salmonella Outbreak Linked to Papa Murphy’s Cookie Dough |
Keller and Heckman LLP |
May 25 2023 |
Minnesota Legislature Passes New Recreational Marijuana Bill |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
May 25 2023 |
EPA Will Propose Updates to New Chemicals Regulations to Improve Efficiency, Remove LVE and LoREX Exemptions for PFAS and Certain PBTs |
Bergeson & Campbell, P.C. |
May 25 2023 |
FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities |
Nelson Mullins |
May 25 2023 |
White House OSTP Extends Comment Period for RFI on NNI EHS Research Strategy |
Bergeson & Campbell, P.C. |
May 24 2023 |
Implementation of FASTER Act Poses Challenge for Industry |
Keller and Heckman LLP |
May 24 2023 |
Sequencing the Impact: How AI is Boosting Genomic Medicine |
Foley & Lardner LLP |
May 24 2023 |
Mississippi Department of Health Revises Medical Cannabis Regulations: Feels Like I’ve Been Here Before |
Bradley Arant Boult Cummings LLP |
May 23 2023 |
Registration Opens for NNI’s Second Webinar on U.S. Government Activities Addressing Micro- and Nanoplastic Issues |
Bergeson & Campbell, P.C. |
May 23 2023 |
Marijuana in the Manufacturing Workplace |
Jackson Lewis P.C. |
May 23 2023 |
More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate |
Epstein Becker & Green, P.C. |